Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Growth factor expression in breast tissue.

R C Coombes1, P Barrett-Lee, Y Luqmani

  • 1Department of Medical Oncology, St. George's Hospital Medical School, London, England.

The Journal of Steroid Biochemistry and Molecular Biology
|December 20, 1990
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Author Correction: Dose escalation and expansion cohorts in patients with advanced breast cancer in a Phase I study of the CDK7-inhibitor samuraciclib.

Nature communications·2025
Same author

An original study assessing biomarker success rate in breast cancer recurrence biomarker research.

BMC medicine·2024
Same author

Author Correction: Dose escalation and expansion cohorts in patients with advanced breast cancer in a Phase I study of the CDK7-inhibitor samuraciclib.

Nature communications·2023
Same author

Dose escalation and expansion cohorts in patients with advanced breast cancer in a Phase I study of the CDK7-inhibitor samuraciclib.

Nature communications·2023
Same author

Author Correction: Results of the phase IIa RADICAL trial of the FGFR inhibitor AZD4547 in endocrine resistant breast cancer.

Nature communications·2023
Same author

Results of the phase IIa RADICAL trial of the FGFR inhibitor AZD4547 in endocrine resistant breast cancer.

Nature communications·2022
Same journal

The Microbiome-Gut-Gonad Axis: How Microbial Metabolites Orchestrate Reproductive Physiology, Pathology, and Therapy.

The Journal of steroid biochemistry and molecular biology·2026
Same journal

L-arginine improves prenatal and pre-pubertal codeine-induced steroidogenesis deregulation by suppressing oxidative stress-dependent signaling in male wistar rats.

The Journal of steroid biochemistry and molecular biology·2026
Same journal

Discovery of 17-imidazo[1,2-a]pyridinyl-3α-hydroxy-5α-androstanes (17IPAs) as novel potent positive allosteric modulators of the GABA<sub>A</sub> receptor: Synthesis, in vitro and in silico studies.

The Journal of steroid biochemistry and molecular biology·2026
Same journal

Androgen receptor as therapeutic indicator for LAR-positive triple-negative breast cancer: Preclinical and clinical assessment.

The Journal of steroid biochemistry and molecular biology·2026
Same journal

The 24,25(OH)<sub>2</sub>D<sub>3</sub>-TLCD3B signaling complex and reproductive function in mice and men.

The Journal of steroid biochemistry and molecular biology·2026
Same journal

Testosterone and epitestosterone differentially regulate UDP-glucuronosyltransferases (UGT) activity.

The Journal of steroid biochemistry and molecular biology·2026
See all related articles

This study investigated growth factor mRNA in breast tissues. Transforming growth factor-beta (TGFb) mRNA was elevated in breast cancer, while epidermal growth factor receptor (EGFR) mRNA showed an inverse relation to estrogen receptor status.

Area of Science:

  • Molecular Biology
  • Oncology
  • Biochemistry

Background:

  • Growth factors play crucial roles in cell proliferation and differentiation.
  • Aberrant expression of growth factors is implicated in breast cancer development.
  • Understanding growth factor signaling pathways is vital for targeted therapies.

Purpose of the Study:

  • To analyze mRNA expression levels of various growth factors and their receptors in malignant, benign, and normal breast tissues.
  • To investigate the correlation between growth factor mRNA expression and clinicopathological features, such as estrogen receptor status.

Main Methods:

  • Quantitative analysis of mRNA levels using biopsy specimens.
  • Detection of mRNA for Transforming Growth Factor-beta (TGFb), Transforming Growth Factor-alpha (TGFa), Epidermal Growth Factor Receptor (EGFR), Platelet-Derived Growth Factor (PDGF) a and b chains, and Insulin-like Growth Factor II (IGF-II).

Related Experiment Videos

Main Results:

  • TGFb mRNA levels were significantly higher in breast cancer tissues compared to benign and normal tissues (P = 0.01).
  • EGFR mRNA was detected in 55% of breast cancers, with its presence inversely related to estrogen receptor status. Coexpression of TGFa and EGFR was more common in estrogen receptor-negative tumors (P = 0.01).
  • PDGF transcripts were found in all normal and malignant tissues, while IGF-II mRNA was present in all non-malignant samples but only 52% of carcinomas.

Conclusions:

  • TGFb mRNA overexpression is a hallmark of breast cancer.
  • The inverse relationship between EGFR and estrogen receptor status suggests distinct signaling pathways in different breast cancer subtypes.
  • Differential expression patterns of growth factors highlight their complex roles in breast tumorigenesis.